Clinical Medicine: Cardiology
Synopsis: An open access, peer reviewed electronic journal that covers prevention, diagnosis and management of cardiovascular disorders.
Indexing: 6 major databases. Pubmed indexing for NIH-funded research.
Processing time: Decision in 2 weeks for 90% of papers.
Visibility: Most popular article read 1400+ times.
About this journal
Aims and scope:
Clinical Medicine: Cardiology is an international, open access, peer reviewed journal which considers manuscripts on the prevention, diagnosis and management of cardiovascular disorders, in addition to related genetic, pathophysiological and epidemiological topics.
Editorial standards and procedures:
Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers. Reviewers are required to provide fair, balanced and constructive reports.
Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair. Appeals are considered by the Editor in Chief or Associate Editor.
Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.
Indexing:
This journal is indexed by the following services:
- Google Scholar
- CAS
- DOAJ
- SCOPUS
- Embase
- OAIster
SPARC Europe Seal award winner:
This journal has been awarded a SPARC Europe Seal. The Seal is an initiative of SPARC Europe (Scholarly Publishing and Academic Resources Coalition) and the Directory of Open Access Journals (DOAJ) which is awarded to journals applying a Creative Commons CC-BY copyright license and that make journal metadata accessible to DOAJ.
Amongst other important services DOAJ makes metadata OAI-compliant. This in turn enhances the visibility of papers and allows OAI-harvesters to include the details of journal articles in their services. We encourage readers to make use of this valuable resource. The DOAJ search page is available here.
National Institutes of Health Public Access Policy compliant:
As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.
If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf.
Call for papers:
The Editor in Chief welcomes submissions. Submissions of the following types are invited:
- Original research articles.
- Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. They may cover basic science and clinical reviews, ethics, pro/con debates, and equipment reviews.
- Commentaries: focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue.
- Hypotheses: articles that present an original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
- Letters to the Editor: these can be either a re-analysis of a previously published article, or a response to such a re-analysis from the authors of the original publication.
- Methodology articles: these discuss a new experimental method, test or procedure. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
- Short reports: brief reports of data from original research.
- Meeting reports: a report pertaining to activity at a meeting or conference Articles published in this journal are immediately available without delay upon publication and enjoy substantial visibility.
- Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Case reports must meet appropriate ethical standards.
All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy. Copyright in published articles remains with the author(s). Authors are continually informed of the progress of their paper and our staff are friendly and responsive.
One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."
Criteria for publication:
Publication is dependent on peer reviewers' judgement of papers. Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility.
Previous work in the field must be acknowledged and papers should read without unreasonable difficulty. Papers should fit comfortably within the scope of the journal.
Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research. They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible.
More information on the role of peer reviewers is available on the information for reviewers page. Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.
Articles submitted to other journals:
We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication.
Services for authors:
Prior to peer review of your paper we can:
- Have your paper's reference style revised to meet our requirements,
- Have your paper's English revised by specialist English-speaking technical editors.
After peer review of your paper we can:
- Have your paper revised in accordance with peer reviewer's recommendations and have a summary of responses to the reviewers created by our specialist external substantive editors,
- Provide bound reprints of your article in colour or black and white ,
- Provide online-early rapid publication if your paper prior to typesetting.
What other authors have said:
Libertas Academica actively requests, receives and acts upon feedback from authors, readers and editorial boards. Here's what some recent authors have said about us:
"Within a couple of days the reviewers had been procured and the manuscript was out."
"The communication between your staff and me has been terrific. Whenever progress is made with the manuscript, I receive notice. Quite honestly, I've never had such complete communication with a journal."
"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."
Article processing fees:
All submissions to this journal are subject to an article processing fee if they are accepted for publication. Article processing fees are used to fund the processing of your paper and development of the journal. Article processing fees are the only compulsory charge you will face and do not vary according to word count, page count, colour figures or any other factor. There is no additional charge for the author(s) to make any use of their article and no charge to readers to access it.
Full fee waivers are available for authors working in undeveloped nations and partial discounts of 20-50% are available to authors in other nations. Authors must be able to verifiably demonstrate their suitability for a discount or waiver. Availability of waivers and discounts is subject to monthly availability and is given at the publisher's discretion. Waivers and discounts must be applied for prior to submission. Neither are available after submission.
Register as a peer reviewer:
Do you wish to register as a peer reviewer? Or are you already a registered peer reviewer but you need to update your contact details? To register or update your details visit the peer reviewer registration form.
Applicants must be able to demonstrate at least five years of continuous experience in the journal's subject area including at least two in the previous 24 months.
Journal newsletter sent to subscribers in week 24, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 22, 2009. Register to receive future newsletters.
Follow this journal on Twitter
Journal newsletter sent to subscribers in week 17, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 16, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 15, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 9, 2009. Register to receive future newsletters.
New call for papers sent to newsletter subscribers in week 8 2009. Readers who wish to be elligible to receive CFPs should subscribe to the newsletter.
Journal newsletter sent to subscribers in week 7, 2009. Register to receive future newsletters.
Peer reviewers are sought. Click here to apply or to update your details.
This journal has been accepted for indexing by Elsevier's highly regarded SCOPUS index
Therapeutic Implications of Coronary Artery Calcium Using Cardiac Computed Tomography
Adonis Saremi and Rohit Arora
Department of Medicine, Chicago Medical School, North Chicago, IL.
Abstract: The objective of this document is to review the clinical applicability of coronary artery calcium (CAC) scoring in both asymptomatic and symptomatic patients at risk for cardiovascular disease. We begin by describing the pathological basis of atherosclerosis, the characteristic stages of atherosclerotic plaque development, and the mechanism and role of arterial calcification in advanced atherosclerotic lesions. We also explain the utility of CAC scoring in cardiovascular risk assessment, discuss the most current clinical methods for measuring CAC, and examine major clinical studies reporting CAC scores in both asymptomatic and symptomatic heart patients. Lastly, the current recommendations for CAC scoring as stated by the American College of Cardiology/American Heart Association (ACC/AHA) are outlined, and a number of considerations for future research are provided. Atherosclerosis begins when certain factors cause chronic endothelial injury, which eventually leads to the build up of fi brofatty plaques in the intima of arterial blood vessels. In time, blood vessel walls can weaken, thrombi can form and plaques can send emboli to distal sites. There are six characteristic stages of plaque development. Mature plaques may be calcified in an active process comparable to bone remodeling, where calcium phosphate crystals coalesce among lipid particles inside arterial walls. Calcification is only present in atherosclerotic arteries, and the site and levels of calcium are non-linearly and positively associated with luminal narrowing of coronary vessels. Calcification is also postulated to stabilize vulnerable plaques in atherosclerotic vessels. Recent studies have shown that CAC scoring can improve the management of both asymptomatic and symptomatic heart patients. Electron beam computed tomography (EBCT) and Multidetector computed tomography (MDCT) are two fast cardiac CT methods used to measure CAC. No matter what technique one uses, CAC is scored with either the Agatston or the “volume” score system. The ACC/AHA currently finds it is reasonable for asymptomatic patients with intermediate Framingham risk scores (FRS) to undergo CAC assessment because these patients can be re-stratified into the high risk category if their CAC scores are 400. Conversely, CAC measurement in asymptomatic patients with low or high FRS is not warranted. There is also no evidence to suggest that high risk asymptomatic patients with no detectable coronary calcium should not be treated with secondary prevention medical therapy. For symptomatic patients, the ACC/AHA recommends CAC assessment as a second line technique to diagnose obstructive CAD, or when primary testing modalities are not possible or are unclear. Furthermore, they do not recommend the use of CAC measurement to determine the etiology of cardiomyopathy, to help identify patients with acute MI in the emergency room, or to assess the progression or regression of coronary atherosclerosis. Future research needs to incorporate calcium scores with percentile rankings, larger population samples, more women with at least intermediate Framingham risk, sufficient numbers of non-Caucasians, reports on cost-effectiveness, and data on populations with Chronic Kidney Disease, End Stage Renal Disease and Diabetes.
Readers of this also read:
- Cellular Therapy for Cardiovascular Disease Part 1 – Preclinical Insights
- Outcome of Infective Endocarditis: Improved Results Over 18 Years (1990–2007)
- Methods for Handling Inter-Hospital Transfer in acute Myocardial Infarction Research
- Methods for Detection of Matrix Metalloproteinases as Biomarkers in Cardiovascular Disease
- Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
- 08/Jun/2009
Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk
- 27/May/2009
Improvement of Young and Elderly Patient’s Knowledge of Heart Failure After an Educational Session
- 20/Apr/2009
Platypnea-Orthodeoxia Syndrome in Two Previously Healthy Adults: A Case-based Review
- 09/Apr/2009
The Threshold of Admission Glycemia as a Predictor of Adverse Events in Diabetic and Non-Diabetic Patients with Acute Coronary Syndrome
- 01/Apr/2009
Age-Related Alteration of Risk Profile, Inflammatory Response, and Angiographic Findings in Patients with Acute Coronary Syndrome
- 18/Feb/2009
Initial Cardiac Rhythm Correlated to Emergency Department Survival
- 09/Feb/2009
Factors Influencing Response to Cardiac Resynchronization Therapy in Patients with Heart Failure (Provisional PDF)
- 20/Jan/2009
Relationship Between the Plasma Concentration of C-Reactive Protein and Severity of Peripheral Arterial Disease
- 23/Dec/2008
The Effect of Chronic Anti-Hypertensive Therapy with Bendroflumethiazide on Sympathetic Drive
- 04/Nov/2008
Time to Medical Management in Patients Presenting with Non-ST Elevation Myocardial Infarction: A Retrospective Analysis of Two Teaching Hospitals
- 19/Sep/2008
Orthostatic Hypotension and Autonomic Failure: A Concise Guide to Diagnosis and Management
- 18/Sep/2008
Heat Shock Proteins in Cardiovascular Stress
- 07/Aug/2008
Exercise-Echocardiography–Derived Pulmonary Artery Pressure Slope in Borderline and Mild to Moderate Pulmonary Arterial Hypertension
- 08/Jul/2008
Fever and Peripheral Emboli in an Immunocompetent Host. A Case of Aspergillus Endocarditis
- 02/Jul/2008
Effect of Oxidative Stress on the Status of Adhesion Molecules, Nuclear Receptors and Cholesterol Flux in Endothelial Cells: Priming of Monocytes
- 17/Jun/2008
Knowledge of “Heart Attack” Symptoms in a Canadian Urban Community
- 21/May/2008
Treatment of Coronary Spastic Angina, Particularly Medically Refractory Coronary Spasm
- 14/May/2008
Cyclooxygenase-2 in Cardiovascular Biology
- 14/May/2008
Proteomic Analysis of Circulating Monocytes Identifies Cathepsin D as A Potential Novel Plasma Marker of Acute Coronary Syndromes
- 14/May/2008
Comparison of Invasive vs Noninvasive Pulse Wave Indices in Detection of Significant Coronary Artery Disease: Can We Use Noninvasive Pulse Wave Indices as Screening Test
- 01/May/2008
Nanoparticles as contrast agents for MRI of atherosclerotic lesions
- 22/Apr/2008
Outcome of Infective Endocarditis: Improved Results Over 18 Years (1990–2007)
- 22/Apr/2008
Periodontitis and Calculated Risk of Cardiovascular Mortality
- 18/Apr/2008
Cellular Therapy for Cardiovascular Disease Part 1 – Preclinical Insights
- 18/Apr/2008
Cellular Therapy for Cardiovascular Disease Part 2 – Delivery of Cells and Clinical Experience
- 18/Apr/2008
Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
- 16/Apr/2008
The Diagnostic Value of B Natriuretic Peptide in Elderly Patients with Acute Dyspnea
- 27/Mar/2008
5-Fluorouracil-Induced Chest Pain and ST-Segment Elevation
- 26/Mar/2008
The Pulsed Doppler Predictors of Intra Dialysis Hypotension and Relationship between Doppler Indices and Net Fluid Loss after Dialysis in Patients with End Stage Renal Disease: Pulsed Doppler Study
- 26/Mar/2008
Methods for Detection of Matrix Metalloproteinases as Biomarkers in Cardiovascular Disease
- 17/Mar/2008
DNA Micro-Array Gene Expression Profi ling of Angiogenesis in Collagen Gel Culture
- 01/Mar/2008
Echocardiographic Improvements with Pacemaker Optimization in the Chronic Post Cardiac Resynchronization Therapy Setting
- 29/Feb/2008
Cardiac Surgery in Patients with Drug Eluting Stents:The Risk of Stopping Clopidogrel
- 09/Feb/2008
Coronary CT Angiography Findings in Patients with Ambiguous Left Main Coronary Artery Disease
- 09/Feb/2008
Methods for Handling Inter-Hospital Transfer in acute Myocardial Infarction Research
- 09/Feb/2008
Cardiovascular Risk Reduction in Diabetes in Sub-Saharan Africa: What should the Priorities be in the Absence of Global Risk Evaluation Tools?
- 09/Feb/2008
Contrast-Enhanced Cardiac Magnetic Resonance Imaging Accurately Differentiates Ischemic from Non-Ischemic Etiologies in Newly Diagnosed Cardiomyopathy
- 09/Feb/2008
Peripheral Arterial Disease Evaluation in the Saudi Project for Assessment of Coronary Events Registry Reveals a Missed Opportunity in Preventing the Adverse Cardiovascular Outcomes: A Pilot Study (SPACE-PAD-I)
- 09/Feb/2008
Arterial Stiffening is Associated with Exercise Intolerance and Hyperventilatory Response in Patients with Coronary Artery Disease
- 09/Feb/2008
Assessment of Fetal Autonomic Nervous System Activity by Fetal Magnetocardiography
- 09/Feb/2008
Late Intervention on an Occluded Infarct-Related Artery: A Meta-analysis of The Randomized Controlled Trials
- 13/Dec/2007
Implantation of an Endovenous Pacemaker in a Patient with Parkinson’s Disease and Bilateral Deep Brain Stimulators
- 11/Dec/2007
Therapeutic Implications of Coronary Artery Calcium Using Cardiac Computed Tomography
- 16/Oct/2007
Cilnidipine and Telmisartan Similarly Improves Vascular Damage in Hypertensive Patients
- 26/Sep/2007